These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 2675480)
1. [Leakage measurements with the dye extraction method and direct methotrexate level determination (enzyme immunoassay) during and after regional cytostatic limb perfusion]. Krauss J; Krause G; Hellthaler G Z Exp Chir Transplant Kunstliche Organe; 1989; 22(4):260-3. PubMed ID: 2675480 [TBL] [Abstract][Full Text] [Related]
2. [Dye concentration measurements for the determination of leakage during and following normothermic cytostatic perfusion in the treatment of tumors of the extremities]. Krauss J; Lange U; Pauer HD; Krauss I Z Exp Chir Transplant Kunstliche Organe; 1984; 17(5):269-74. PubMed ID: 6095550 [TBL] [Abstract][Full Text] [Related]
3. [Dye dilution test to determine leakage during regional perfusion in the treatment of malignant tumors of the extremities]. Ghussen F; Isselhard W; Sturz J; Welte CP; Stock W; Müller EW Chir Forum Exp Klin Forsch; 1979; ():165-8. PubMed ID: 378584 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. Kam PC; Thompson JF Surg Oncol Clin N Am; 2008 Oct; 17(4):795-804, ix. PubMed ID: 18722919 [TBL] [Abstract][Full Text] [Related]
9. [Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value?]. Meyer T; Göhl J; Hohenberger W Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1452-4. PubMed ID: 9931909 [TBL] [Abstract][Full Text] [Related]
10. History of regional chemotherapy for cancer of the extremities. Ariyan CE; Brady MS Int J Hyperthermia; 2008 May; 24(3):185-92. PubMed ID: 18392997 [TBL] [Abstract][Full Text] [Related]
11. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha. Laurenzi L; Natoli S; Di Filippo F; Calamaro A; Centulio F; Anzà M; Cavaliere F; Marcelli ME; Garinei R; Arcuri E J Exp Clin Cancer Res; 2004 Jun; 23(2):225-31. PubMed ID: 15354406 [TBL] [Abstract][Full Text] [Related]
12. The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models. Eggermont AM Gan To Kagaku Ryoho; 1996 Sep; 23(11):1357-70. PubMed ID: 8854755 [No Abstract] [Full Text] [Related]
13. Treatment of melanoma in-transit metastases confined to the limb. Eggermont AM Cancer Surv; 1996; 26():335-49. PubMed ID: 8783582 [No Abstract] [Full Text] [Related]
14. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730 [TBL] [Abstract][Full Text] [Related]
15. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor. Fraker DL; Alexander HR; Andrich M; Rosenberg SA Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465 [TBL] [Abstract][Full Text] [Related]
16. Isolated limb perfusion for unresectable melanoma of the extremities. Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572 [TBL] [Abstract][Full Text] [Related]
17. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma. Fraker DL; Alexander HR Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489 [No Abstract] [Full Text] [Related]
18. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion. Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605 [TBL] [Abstract][Full Text] [Related]